ICC Capital Management’s AbbVie ABBV Stock Holding History

ICC Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$8K	Sell	130 -83,068	-100%	-$5.02M	﹤0.01%	234
2014 Q4	$5.44M	Sell	83,198 -26,640	-24%	-$1.68M	0.71%	49
2014 Q3	$6.34M	Sell	109,838 -201,658	-65%	-$11.2M	0.77%	45
2014 Q2	$17.6M	Sell	311,496 -91,945	-23%	-$4.82M	1.85%	6
2014 Q1	$20.7M	Buy	403,441 +235,735	+141%	+$11.9M	1.87%	7
2013 Q4	$8.86M	Sell	167,706 -7,915	-5%	-$389K	0.74%	51
2013 Q3	$7.86M	Sell	175,621 -3,200	-2%	-$142K	0.57%	66
2013 Q2	$7.39M	Buy	+178,821	New	+$7.82M	0.53%	60

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ICC Capital Management's ABBV Position: Q1 2015 in Review

ICC Capital Management reduced its AbbVie (ABBV) stake by 100% in Q1 2015, selling an estimated $5.02M and leaving 130 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #234.

ICC Capital Management first reported a position in ABBV in Q2 2013 and has held it in 8 quarters since. The position peaked at $20.7M in Q1 2014. 1,601 funds tracked by Wall St. Rank hold ABBV as of Q1 2015.

ICC Capital Management held 130 shares of AbbVie worth $8K as of Q1 2015.
ICC Capital Management sold 83,068 AbbVie shares in Q1 2015, an estimated $5.02M.
AbbVie made up ﹤0.01% of ICC Capital Management's portfolio in Q1 2015, its #234 holding.
ICC Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 8 quarters since.
ICC Capital Management's AbbVie position peaked at $20.7M in Q1 2014.
1,601 funds tracked by Wall St. Rank held AbbVie as of Q1 2015.

Based on ICC Capital Management's 13F filing for Q1 2015, filed 13 May 2015.